New drugs for rheumatoid arthritis

Med Lett Drugs Ther. 1998 Nov 20;40(1040):110-2.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Clinical Trials as Topic
  • Diarrhea / chemically induced
  • Drug Interactions
  • Etanercept
  • Fees, Pharmaceutical
  • Humans
  • Immunoglobulin G / metabolism
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Isoxazoles / adverse effects
  • Isoxazoles / pharmacokinetics
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Receptors, Tumor Necrosis Factor / metabolism
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Tumor Necrosis Factor-alpha / drug effects

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Isoxazoles
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Leflunomide
  • Etanercept